We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.05B
AUM Growth
-$157M
Cap. Flow
-$123M
Cap. Flow %
-11.81%
Top 10 Hldgs %
60.57%
Holding
47
New
9
Increased
9
Reduced
18
Closed
11

Top Buys

Rank Stock Value
1
TWST icon
Twist Bioscience
TWST
+$55.4M
2
IRTC icon
iRhythm Holdings
IRTC
+$33.8M
3
MDXG icon
MiMedx Group
MDXG
+$26M
4
EWTX icon
Edgewise Therapeutics
EWTX
+$24.9M
5
VERA icon
Vera Therapeutics
VERA
+$24.6M

Top Sells

Rank Stock Value
1
EVH icon
Evolent Health
EVH
+$39.4M
2
PODD icon
Insulet
PODD
+$31.5M
3
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$31.5M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$24.8M
5
DYN icon
Dyne Therapeutics
DYN
+$24.8M

Sector Composition

Rank Sector Weight
1 Healthcare 99.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPCR icon
26
Structure Therapeutics
GPCR
$3.41B
$10.8M 1.04%
398,855
-107,367
-21% -$3.81M
TNDM icon
27
Tandem Diabetes Care
TNDM
$1.34B
$10.5M 1.01%
292,117
-733,190
-72% -$24.8M
DYN icon
28
Dyne Therapeutics
DYN
$4.7B
$9.91M 0.95%
420,431
-836,854
-67% -$24.8M
ELDN icon
29
Eledon Pharmaceuticals
ELDN
$261M
$9.59M 0.92%
+2,328,768
New +$9.18M
GH icon
30
Guardant Health
GH
$21.5B
$9.45M 0.9%
309,389
-339,604
-52% -$9.55M
PODD icon
31
Insulet
PODD
$11.5B
$8.83M 0.84%
33,821
-125,261
-79% -$31.5M
TMDX icon
32
Transmedics
TMDX
$2.64B
$8.71M 0.83%
139,757
-125,977
-47% -$11.7M
OSCR icon
33
Oscar Health
OSCR
$9.41B
$7.35M 0.7%
546,822
-1,219,070
-69% -$19.6M
SENS icon
34
Senseonics Holdings Inc
SENS
$263M
$3.37M 0.32%
+321,590
New +$2.3M
EVH icon
35
Evolent Health
EVH
$348M
$603K 0.06%
53,620
-2,244,641
-98% -$39.4M
IWO icon
36
iShares Russell 2000 Growth ETF
IWO
$14.3B
$348K 0.03%
+1,208
New +$357K
ASND icon
37
Ascendis Pharma A/S
ASND
$16B
– –
-51,723
Closed -$7.72M
ATEC icon
38
Alphatec Holdings
ATEC
$1.46B
– –
-138,006
Closed -$767K
AVTR icon
39
Avantor
AVTR
$9.32B
– –
-359,150
Closed -$9.29M
BCYC
40
Bicycle Therapeutics
BCYC
$269M
– –
-967,006
Closed -$21.9M
EXAS
41
DELISTED
Exact Sciences
EXAS
– –
-69,447
Closed -$4.73M
MOH icon
42
Molina Healthcare
MOH
$10.2B
– –
-26,528
Closed -$9.14M
OPRX icon
43
OptimizeRx
OPRX
$114M
– –
-1,811,611
Closed -$14M
RLAY icon
44
Relay Therapeutics
RLAY
$4.1B
– –
-1,542,406
Closed -$10.9M
NARI
45
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-174,590
Closed -$7.2M
CDMO
46
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
-2,771,853
Closed -$31.5M
SONX
47
DELISTED
Sonendo, Inc.
SONX
– –
-5,886,207
Closed -$254K
1
2

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, First Light Asset Management held 47 positions worth $1.05B, down 13% from $1.2B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

First Light Asset Management withdrew a net $123M in Q4 2024, closing 11 positions and reducing 18 holdings. Its most notable exit was Avid Bioservices, Inc. Common Stock, an estimated $31.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, down from 100% a quarter earlier.

Against the trend, First Light Asset Management opened a new position in Twist Bioscience worth $57M.

  • First Light Asset Management's largest Q4 2024 buy was Twist Bioscience: 1,226,255 shares worth $57M.
  • First Light Asset Management added most to Vera Therapeutics in Q4 2024, an estimated $24.6M increase.
  • First Light Asset Management's biggest Q4 2024 reduction was Evolent Health, cutting an estimated $39.4M.
  • First Light Asset Management fully exited Avid Bioservices, Inc. Common Stock in Q4 2024, selling an estimated $31.5M.
  • First Light Asset Management's ten largest holdings make up 61% of its $1.05B portfolio in Q4 2024.
  • First Light Asset Management opened 9 new positions and closed 11 in Q4 2024.
  • First Light Asset Management's portfolio value fell 13% quarter-over-quarter to $1.05B.

Based on First Light Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.